Ajax-Loading

Novartis AG - Other Current Liabilities

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Current-Liabilities" stands at 16.32 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Other Current Liabilities" stands at 16.32 Billion USD. This represents an increase of 3.23 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.31 percent compared to the value the year prior.
The 1 year change in percent is 8.31.
The 3 year change in percent is 21.11.
The 5 year change in percent is 13.13.
The 10 year change in percent is 16.20.

The Serie's long term average value is 13.86 Billion United States Dollars. It's latest available value, on 09/30/2025, is 17.77 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is +82.50%.
The Serie's change in percent from it's maximum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is -61.09%.

Other Current Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Current Liabilities905,699,262,464.00
LogoJohnson & Johnson - Other Current Liabilities486,508,953,600.00
LogoAbbVie Inc - Other Current Liabilities399,570,305,024.00
LogoRoche Holding AG - Other Current Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Other Current Liabilities280,205,508,085.11